Zheng 2023 — MOTS-c Therapeutic Exploitation Review

Frontiers in Endocrinology·January 1, 2023

Yuejun Zheng, et al.

Summary

Review of MOTS-c biology as a mitochondrial-derived peptide involved in metabolic regulation, stress adaptation, and therapeutic research across metabolic and aging-related conditions.

Study Details

Study Design

Narrative review

Indication

Metabolic disease, aging biology, and mitochondrial-derived peptide signaling

Intervention

MOTS-c

Species

Human

Risk of Bias Assessment

Review; clinical translation remains limited